- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Evidence-Based Collaborative Program for Cancer Care Launched in California
A collaboration between Aetna, MOASC Contracting Network and Cardinal Health Specialty Solutions aims to improve quality and cost of cancer care in California.
Aetna, the MOASC Contracting Network and Cardinal Health Specialty Solutions announced today the launch of an evidence-based program designed to improve cancer care in California. The program is available to Aetna network oncologists who are members of the MOASC Contracting Network.
This program identifies clinical best practices that improve cancer treatment and make it more affordable. Participating physicians have access to PathWare(TM) Decision Transaction Solutions, a tool that provides them with real-time decision support at the point of care, including easy access to clinical pathways for various types of cancer.
"We are committed to working with the oncology community to make cancer care safer and more effective," said Michael Kolodziej, M.D., Aetna's national medical director for Oncology Strategy. "Through this joint effort, we want to help doctors base treatment decisions on the most current medical evidence, which leads to better patient outcomes."
Read the press release: http://on.wsj.com/POloH5
Source: The Wall Street Journal
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
